Latent tuberculosis infection: old problem, new priorities.
作者信息
Schwartzman Kevin
机构信息
Respiratory Division, McGill University Health Centre, Montreal, Que.
出版信息
CMAJ. 2002 Mar 19;166(6):759-61.
Abstract
摘要
相似文献
1
Latent tuberculosis infection: old problem, new priorities.潜伏性结核感染：老问题，新重点。
CMAJ. 2002 Mar 19;166(6):759-61.
2
New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement.关于儿童和青少年潜伏性结核感染的新指南：一项值得欢迎的进展。
Pediatrics. 2004 Oct;114(4):1084-6. doi: 10.1542/peds.2004-1525.
3
Priorities for the treatment of latent tuberculosis.潜伏性结核病的治疗重点
N Engl J Med. 2004 Aug 19;351(8):832-4; author reply 832-4.
4
Priorities for the treatment of latent tuberculosis.潜伏性结核病的治疗重点
N Engl J Med. 2004 Aug 19;351(8):832-4; author reply 832-4.
5
Mantoux (tuberculosis) testing. Evaluation of guidelines for testing in Canadian institutions.结核菌素（结核病）试验。加拿大机构中检测指南的评估。
Can Fam Physician. 1997 May;43:933-8.
6
Management of tuberculosis in the United States.美国的结核病管理
N Engl J Med. 2001 Jul 19;345(3):189-200. doi: 10.1056/NEJM200107193450307.
7
Clinical practice. Latent tuberculosis infection.临床实践。潜伏性结核感染。
N Engl J Med. 2002 Dec 5;347(23):1860-6. doi: 10.1056/NEJMcp021045.
8
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.美国和加拿大潜伏性结核感染治疗的范围及影响
Am J Respir Crit Care Med. 2006 Aug 15;174(4):480; author reply 481. doi: 10.1164/ajrccm.174.4.480.
9
Tuberculosis--elimination in the third millennium?结核病——第三个千年能否消除？
Med Health R I. 2002 Feb;85(2):48-51.
10
Priorities for the treatment of latent tuberculosis.潜伏性结核病的治疗重点
N Engl J Med. 2004 Aug 19;351(8):832-4; author reply 832-4. doi: 10.1056/NEJM200408193510823.
引用本文的文献
1
Adverse events associated with treatment of latent tuberculosis in the general population.普通人群潜伏性结核治疗的不良反应。
CMAJ. 2011 Feb 22;183(3):E173-9. doi: 10.1503/cmaj.091824. Epub 2011 Jan 10.
2
3
Latent tuberculosis treatment.潜伏性结核病治疗
CMAJ. 2002 Sep 3;167(5):452-3; author reply 453-4.
本文引用的文献
1
A CONTROLLED TRIAL OF ISONIAZID PROPHYLAXIS IN MENTAL INSTITUTIONS.精神病院中异烟肼预防治疗的对照试验。
Am Rev Respir Dis. 1963 Aug;88:161-75. doi: 10.1164/arrd.1963.88.2.161.
2
Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations--United States, 2001.最新消息：利福平与吡嗪酰胺用于潜伏性结核感染导致的致命性和严重性肝损伤，以及美国胸科学会/疾病控制与预防中心建议的修订——美国，2001年
MMWR Morb Mortal Wkly Rep. 2001 Aug 31;50(34):733-5.
3
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.与英夫利昔单抗（一种肿瘤坏死因子α中和剂）相关的结核病。
N Engl J Med. 2001 Oct 11;345(15):1098-104. doi: 10.1056/NEJMoa011110.
4
Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.密切接触者和外国出生人群结核病筛查的成本效益比较。
Am J Respir Crit Care Med. 2000 Dec;162(6):2079-86. doi: 10.1164/ajrccm.162.6.2001111.
5
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.潜伏性结核感染的靶向结核菌素检测与治疗。本美国胸科学会官方声明于1999年7月由ATS董事会通过。这是美国胸科学会（ATS）与疾病控制和预防中心（CDC）的联合声明。本声明于1999年9月得到美国传染病学会（IDSA）理事会的认可，以及本声明的各章节。
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47. doi: 10.1164/ajrccm.161.supplement_3.ats600.
6
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.利福平与吡嗪酰胺对比异烟肼用于预防HIV感染者结核病：一项国际随机试验。艾滋病临床研究特里·贝恩社区项目、成人艾滋病临床试验组、泛美卫生组织及疾病控制与预防中心研究小组。
JAMA. 2000 Mar 15;283(11):1445-50. doi: 10.1001/jama.283.11.1445.
7
Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis.低结核病流行率国家移民的结核病筛查。一项成本效益分析。
Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):780-9. doi: 10.1164/ajrccm.161.3.9902005.
8
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?免疫功能正常的成年人预防结核病需要多少异烟肼？
Int J Tuberc Lung Dis. 1999 Oct;3(10):847-50.
9
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.1991 - 1997年旧金山结核病趋势的分子流行病学分析
Ann Intern Med. 1999 Jun 15;130(12):971-8. doi: 10.7326/0003-4819-130-12-199906150-00004.
10
Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.异烟肼预防性治疗相关的肝毒性：来自一家公共卫生结核病诊所的7年调查
JAMA. 1999 Mar 17;281(11):1014-8. doi: 10.1001/jama.281.11.1014.
Zotero 插件